Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
US7115727B2 · kind B2 · utility
4Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2003 |
| Grant date | Oct 3, 2006 |
| Priority date | — |
| Expiry date | Jul 24, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel gene 282P1G3 and its encoded protein, and variants thereof, are described wherein 282P1G3 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 282P1G3 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 282P1G3 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 282P1G3 can be used in active or passive immunization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.